Recent Advances in Diagnosis and Treatment of CNS Tumours
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (29 September 2023) | Viewed by 2109
Special Issue Editor
Special Issue Information
Dear Colleagues,
The 2021 World Health Organization (WHO) classification significantly changed Central Nervous System (CNS) tumours classification. Improvements have been performed in the characterization of CNS tumors to predict survival outcomes. Novel therapeutic approaches, based on cancer biology, are increasingly being used, with promising results on tumor treatment.
This Special Issue will examine innovative approaches to the diagnosis and treatment of CNS tumors.
Researchers are encouraged to submit original research articles on (1) new insights into tissue-based biomarkers and recent advances in CNS tumours diagnosis, stratification, management, and drug development; (2) liquid biopsy; (3) progress in surgical techniques; (4) radiotherapy; (5) clinical trials and immunotherapy; (6) quality of life during and after the treatments; (7) CNS metastases.
Dr. Gianluca Marucci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumors
- liquid biopsy
- neurosurgery
- neuroimaging
- pathology
- gliomas
- glioblastoma
- meningioma
- ependymoma
- genomics
- radiomics
- proteomics
- medulloblastoma
- ependymoma
- secondary malignancies of the CNS
- neuro-oncology
